MedPath

Study on the clinical effect of Ganwei Tongzhi TCM Compound in preventing Barrett's esophageal canceratio

Phase 1
Recruiting
Conditions
Barrett Esophagus
Registration Number
ITMCTR2000003993
Lead Sponsor
Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients 18 years old <= age <= 70 years old, regardless of gender;
2. Patients who meet the diagnostic criteria of be;
3. Patients who understand and agree to participate in the study and sign the informed consent form.

Exclusion Criteria

1. Patients with liver and kidney damage, severe anemia and malignant tumor;
2. Patients who are allergic to the drugs used in this study;
3. Pregnant or lactating women;
4. Patients with mental illness and other patients who are unable to self describe symptoms and understand disorders.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical symptom score;Histopathological observation of the lesion;Lesion area of esophagus;
Secondary Outcome Measures
NameTimeMethod
Immunohistochemical expression of Ki67 protein in pathological tissues;The immune expression of p53 protein in pathological tissues;Determination of microRNA in peripheral blood;
© Copyright 2025. All Rights Reserved by MedPath